Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
AD     Remove this Ad

JAGSONPAL PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 22.0218.3016.1727.996.60

What is the latest EV/Core EBITDA ratio of JAGSONPAL PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of JAGSONPAL PHARMACEUTICALS is 22.02 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202522.02
Mar202418.30
Mar202316.17
Mar202227.99
Mar20216.60

How is EV/Core EBITDA of JAGSONPAL PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 22.02
20.33
Mar2024 18.3
13.17
Mar2023 16.17
-42.23
Mar2022 27.99
324.09
Mar2021 6.6 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹1,235.8 Cr 1.6% 5.7% -18.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

1.6%

5.7%

-18.6%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses